¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀ§¾ÏÇÐȸ 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò : 2023-12-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÀ§¾ÏÇÐȸ 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò : 2023-12-09
±³À°ÀÏÀÚ : 2023-12-09
±³À°Àå¼Ò : °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü 1F ´ë°­´ç

±³À°ÁÖÁ¦ : 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇÑÀ§¾ÏÇÐȸ
´ã´çÀÚ : ±èÁöÇý
¿¬¶ôó : 02-730-3760  

À̸ÞÀÏ : kgca@kgca-i.or.kr

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 55ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 10:20~10:25 Opening remarks ±èÁ¾ÇÑ(°í·Á´ëÇб³)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 10:25~10:30 Congratulatory remarks ·ù±Ù¿ø(´ëÇÑÀ§¾ÏÇÐȸ ÀÌ»çÀå)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 10:30~12:05 [ÁÂÀå] Plenary I: Issues for Intraperitoneal metastasis ÇÏÅ°æ/¹ÚÁß¹Î(ÇѾç´ëÇб³/Áß¾Ó´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 10:30~10:50 Plenary I: RECIST criteria and recent updates for response measurements ±èÁ¤¿ì(°í·Á´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 10:50~11:10 Plenary I: Assessment of Peritoneal Cancer Index ±èµ¿¿í(´Ü±¹´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 11:10~11:30 Plenary I: NK cell treatment for Intraperitoneal carcinomatosis °­Á¤È­(Immunisbio)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 11:30~11:50 Plenary I: Biomarker study for metastatic Gastric Cancer ÃÖÀ±¿µ(¼øõÇâ´ëÇб³)

Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 11:50~12:05 Discussion ±ÇÀαÔ/ÀåÀ¯Áø/À±Á¾Çõ(¿¬¼¼´ëÇб³/°í·Á´ëÇб³/¼øõÇâ´ëÇб³)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 12:05~12:30 [ÁÂÀå] Special Lecture: Phoenix trial ·ù±Ù¿ø(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 12:05~12:30 Special Lecture: Treatment of Intraperitoneal Metastasis in Japan Hironori ishigami(The University of Tokyo)

½Ä»ç 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 12:30~13:30 Lunch .(.)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 13:30~14:45 [ÁÂÀå] Plenary II: Recent update and future perspectives for stage IV gastric cancer ÇãÈÆ/ÀÌÇÑÈ«(¾ÆÁÖ´ëÇб³/°¡Å縯´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 13:30~13:50 Plenary II: Recent updates for palliative chemotherapy ¿À»óö(°í·Á´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 13:50~14:10 Plenary II: Result of IPLUS trial and updates of PIPAC trial °­¼ÒÇö(¼­¿ï´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 14:10~14:30 Plenary II: Result of PIPS-GC PIb/II study and Introduction of PIPS-GC phase 3 trial ¼­¿øÁØ(°í·Á´ëÇб³)

Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 14:30~14:45 Discussion Áø¼ºÈ£/±èÇüÀÏ/¼ÛÁ¤È£(¿øÀڷº´¿ø/¿¬¼¼´ëÇб³/¾ÆÁÖ´ëÇб³)

ÈÞ½Ä 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 14:45~15:05 Coffee Break .(.)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 15:05~16:45 [ÁÂÀå] Plenary III: Sharing Experiences of Intraperitoneal Chemotherapy ±èÁøÁ¶/ÃÖ¼ºÀÏ(°¡Å縯´ëÇб³/°æÈñ´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 15:05~15:25 Plenary III: Experience of Intraperitoneal chemotherapy with PIPS-GC trial ±èÁ¾¿ø(Áß¾Ó´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 15:25~15:45 Plenary III: Experience of Palliative chemotherapy for Peritoneal metastasis ·ùÈÆ(¿¬¼¼´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 15:45~16:05 Plenary III: Experience of intraperitoneal chemotherapy, multiple cases ÀÌâ¹Î(°í·Á´ëÇб³)

±³À°½Ã°£ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 16:05~16:25 Plenary III: Conversion surgery after intraperitoneal chemotherapy for peritoneal metastasis ¹Ú±â¹ü(°æºÏ´ëÇб³)

Åä·Ð 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 16:25~16:45 Discussion ¹ÎÀç¼®/Á¤¹Ì¶õ/À̼¼Áø(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø/Àü³²´ëÇб³/ÀüºÏ´ëÇб³)

±âŸ 12¿ù 09ÀÏ °í·Á´ëÇб³ ±¸·Îº´¿ø »õ·Ò±³À°°ü ´ë°­´ç 16:45~17:00 Closing Celemony ±èÁ¾ÇÑ(°í·Á´ëÇб³)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀ§¾ÏÇÐȸ 2023 À§¾Ï º¹¸·ÀüÀÌ ¿¬±¸ ½ÉÆ÷Áö¿ò : 2023-12-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ VESSEL Update 2023 ½ÉÆ÷Áö¾ö (2ÀÏÂ÷) : 2023-12-09
´ÙÀ½±Û 2023 Á¤½Å½ÅüÀÇÇÐ Àü¹®°¡°úÁ¤ ½Å±Ô±³À° 10ȸ±â : 2023-12-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 8 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 14 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 7 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 5 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 7 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 8 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 3 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 1 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 2 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 4 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 5 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 3 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 4 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 4 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 7 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷